We are live on ! Find out more
PC

Pier Capital Portfolio holdings

AUM $755M
1-Year Est. Return 94.38%
This Fund
S&P 500
This Quarter Est. Return
+39.75%
1 Year Est. Return
+94.38%
3 Year Est. Return
+222.94%
5 Year Est. Return
+261.19%
10 Year Est. Return
+2,769.67%
AUM
$945M
AUM Growth
+$260M
Cap. Flow
+$43.1M
Cap. Flow %
4.56%
Top 10 Hldgs %
14.05%
Holding
130
New
21
Increased
60
Reduced
33
Closed
16

Top Sells

Rank Stock Value
1
ENPH icon
Enphase Energy
ENPH
+$9.24M
2
MMS icon
Maximus
MMS
+$8.87M
3
BJ icon
BJs Wholesale Club
BJ
+$8.14M
4
UNF icon
Unifirst Corp
UNF
+$7.67M
5
APPN icon
Appian
APPN
+$7.45M

Sector Composition

Rank Sector Weight
1 Technology 29.84%
2 Healthcare 24.25%
3 Industrials 16.55%
4 Consumer Discretionary 10.64%
5 Financials 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SI
76
DELISTED
Silvergate Capital Corporation
SI
$8.12M 0.86%
+109,252
New +$3.6M
CCRD
77
DELISTED
CoreCard
CCRD
$8.08M 0.86%
201,556
+6,133
+3% +$242K
IOVA icon
78
Iovance Biotherapeutics
IOVA
$3.05B
$7.68M 0.81%
165,507
-62,057
-27% -$2.46M
APPN icon
79
Appian
APPN
$2.49B
$7.52M 0.8%
46,394
-66,538
-59% -$7.45M
TGTX icon
80
TG Therapeutics
TGTX
$7.58B
$7.51M 0.8%
144,414
-124,390
-46% -$4.2M
SITE icon
81
SiteOne Landscape Supply
SITE
$4.22B
$7.29M 0.77%
45,977
-20,184
-31% -$2.77M
APPF icon
82
AppFolio
APPF
$6.97B
$7.06M 0.75%
39,215
+1,465
+4% +$234K
EB
83
DELISTED
Eventbrite
EB
$6.67M 0.71%
+368,402
New +$5.16M
TNDM icon
84
Tandem Diabetes Care
TNDM
$1.63B
$6.32M 0.67%
66,080
+2,301
+4% +$237K
ITCI
85
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$6.07M 0.64%
+190,833
New +$5.02M
FRPT icon
86
Freshpet
FRPT
$3.48B
$6.01M 0.64%
42,298
+1,411
+3% +$182K
MRTX
87
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$5.95M 0.63%
27,090
+845
+3% +$183K
BLFS icon
88
BioLife Solutions
BLFS
$1.72B
$5.91M 0.63%
+148,087
New +$5.05M
CYRX icon
89
CryoPort
CYRX
$766M
$5.71M 0.6%
130,150
+4,350
+3% +$207K
BHVN
90
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$5.71M 0.6%
66,612
+2,117
+3% +$179K
PRPL icon
91
Purple Innovation
PRPL
$28.4M
$5.46M 0.58%
6,624
-5,559
-46% -$4.05M
FVRR icon
92
Fiverr
FVRR
$311M
$5.4M 0.57%
27,679
-19,527
-41% -$3.53M
TENB icon
93
Tenable Holdings
TENB
$4.41B
$5.32M 0.56%
+101,718
New +$4.03M
OTRK
94
DELISTED
Ontrak
OTRK
$5.19M 0.55%
933
+25
+3% +$136K
CERS icon
95
Cerus
CERS
$572M
$4.93M 0.52%
712,389
+19,647
+3% +$129K
TXRH icon
96
Texas Roadhouse
TXRH
$14.1B
$4.65M 0.49%
59,537
-53,148
-47% -$3.96M
PTCT icon
97
PTC Therapeutics
PTCT
$6.06B
$4.39M 0.46%
71,873
-4,518
-6% -$266K
ALLO icon
98
Allogene Therapeutics
ALLO
$683M
$3.84M 0.41%
152,071
+3,843
+3% +$125K
WOLF icon
99
Wolfspeed
WOLF
$1.64B
$1.05M 0.11%
9,922
+5,463
+123% +$439K
PINS icon
100
Pinterest
PINS
$13.2B
$824K 0.09%
12,502
-7,561
-38% -$454K

Similar funds

Pier Capital's Q4 2020 Portfolio in Review

As of Q4 2020, Pier Capital held 130 positions worth $945M, up 38% from $685M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Pier Capital deployed $43.1M of net new capital in Q4 2020, opening 21 new positions and adding to 60 existing holdings. Its largest new stake was Inari Medical, Inc. Common Stock: 147,211 shares worth $12.8M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 30% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Maximus, an estimated $8.87M trimmed.

  • Pier Capital's largest Q4 2020 buy was Inari Medical, Inc. Common Stock: 147,211 shares worth $12.8M.
  • Pier Capital added most to Vroom Inc in Q4 2020, an estimated $6.17M increase.
  • Pier Capital's biggest Q4 2020 reduction was Maximus, cutting an estimated $8.87M.
  • Pier Capital fully exited Enphase Energy in Q4 2020, selling an estimated $9.24M.
  • Pier Capital's ten largest holdings make up 14% of its $945M portfolio in Q4 2020.
  • Pier Capital opened 21 new positions and closed 16 in Q4 2020.
  • Pier Capital's portfolio value rose 38% quarter-over-quarter to $945M.

Based on Pier Capital's 13F filing for Q4 2020, filed 16 Feb 2021.